国际肿瘤学杂志 ›› 2012, Vol. 39 ›› Issue (12): 905-907.

• 综述 • 上一篇    下一篇

Ⅲ型干扰素的抗肿瘤作用

王晴, 张璐, 沈倩妮, 朱薿, 罗凡, 侯炜   

  1. 430071病毒学国家重点实验室 武汉大学基础医学院
  • 出版日期:2012-12-08 发布日期:2012-11-15
  • 通讯作者: 侯炜,E-mail: houwei@whu.edu.cn E-mail:houwei@whu.edu.cn
  • 基金资助:

    国家自然科学基金资助项目(30972754);教育部留学回国人员科研启动基金资助项目【教外司留2010(609号)】

Anti-tumor effect of Type Ⅲ interferon

WANG  Qing, ZHANG  Lu, SHEN  Qian-Ni, ZHU  Ni, LUO  Fan, HOU  Wei   

  1. State Key Laboratory of Virology; School of Basic Medical Science, Wuhan University, Wuhan 430071, China
  • Online:2012-12-08 Published:2012-11-15
  • Contact: Corresponding author: HOU Wei, E-mail: houwei@whu.edu.cn E-mail:houwei@whu.edu.cn

摘要: 研究发现Ⅲ型干扰素(IFN-λ)具有抗黑色素瘤、肝细胞癌、食管癌、纤维素瘤等的作用。IFN-λ不仅能抑制黑色素瘤的转移,还可引起细胞凋亡;组成性表达的IFN-λ使自然杀伤细胞活化,从而影响肝细胞癌的生长;在食管癌中,IFN-λ能诱导G1期细胞的停滞或直接导致细胞凋亡;IFN-λ可通过诱导固有免疫和适应性免疫反应来抑制体内纤维肉瘤的生长。这些抗肿瘤机制的研究为IFN-λ运用于肿瘤临床治疗提供了新的思路。

关键词: 干扰素类, 肿瘤

Abstract: It is reported that type Ⅲ interferon (IFN-λ) has an anti-tumor effect on melanoma,  hepatocellular carcinoma, esophageal carcinoma and fibrosarcoma in recent years. IFN-λ could not only inhibit melanoma metastasis, but also induce cell apoptosis; its constitutively expression could activate natural killer cells, affecting hepatocellular carcinoma growth; IFN-λ could induce cells of G1 phase in esophageal carcinoma directly to stagnation or apoptosis; IFN-λ could cause native and adaptive immune response to suppress fibrosarcoma growth. Research on the anti-tumor mechanisms of IFN-λ will provide new ideas for clinical tumor therapy.

Key words: Interferons, Neoplasms